Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128938) titled 'Multi-platform Performance Validation of NRM411-S7 CLIA Analyzer and Clinical Application for Whole Blood Specimens' on July 28.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Yancheng First People's Hospital
Condition:
none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-28
Target Sample Size: Observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=331778
Published by HT Digital Content Services with permission from Health Daily Digest....